- Home
- HTFL vs ASTH Comparison
HTFL vs ASTH Comparison
Compare HTFL & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTFL | ASTH |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HTFL | ASTH |
|---|---|---|
| Price | $48.49 | $38.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $38.20 | $34.86 |
| AVG Volume (30 Days) | ★ 2.1M | 270.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.37 | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | $176,034,000.00 | ★ $519,907,752.00 |
| Revenue This Year | $27.66 | $27.38 |
| Revenue Next Year | $23.55 | $10.78 |
| P/E Ratio | ★ N/A | $55.04 |
| Revenue Growth | 39.92 | ★ 45.90 |
| 52 Week Low | $20.13 | $18.08 |
| 52 Week High | $51.78 | $51.60 |
Technical Indicators
Market Signals| Indicator | HTFL | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 66.88 | 55.96 |
| Support Level | $47.13 | $36.52 |
| Resistance Level | $51.48 | $40.11 |
| Average True Range (ATR) | 2.40 | 1.46 |
| MACD | -0.71 | 0.15 |
| Stochastic Oscillator | 64.86 | 89.55 |
Price Performance
Historical ComparisonAbout HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
About ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.